Popular Press
Bitter Battle - US narrative of lack of regulation and poor drugs in India is fed on half-truths
The Week
(2019)
Abstract
Insulin vials contaminated with “black, metallic particles”, improperly sealed caps of drugs used for chemotherapy, garbage bags full of incriminating reports, and data manipulation to get over the United States Food and Drug Administration's regulatory requirements—journalist Katherine Eban's Bottle of Lies: Ranbaxy and the Dark Side of Indian Pharma lists these and more instances of USFDA violations found inside manufacturing plants of certain generic drug manufacturers in India.
Disciplines
Publication Date
August 24, 2019
Citation Information
Srividhya Ragavan. "Bitter Battle - US narrative of lack of regulation and poor drugs in India is fed on half-truths" The Week (2019) Available at: http://works.bepress.com/srividhya_ragavan/279/